Vasundhara Rasayans Reports Significant Financial Decline in March 2025 Results

Vasundhara Rasayans, a microcap company in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending March 2025. The results indicate a notable shift in the company's financial standing, with a revision in its score reflecting the challenges faced during this period.
The Profit Before Tax less Other Income (PBT) for the quarter stands at Rs -0.17 crore, marking a significant deviation from the average PBT of Rs 1.43 crore observed over the previous four quarters. This trend suggests a substantial decline in profitability. Similarly, the Profit After Tax (PAT) for the latest six months is reported at Rs 1.90 crore, which shows a year-on-year contraction of 45.87%.

Net sales for the quarter are recorded at Rs 7.76 crore, which is lower than the average of Rs 9.34 crore from the preceding four quarters. The operating profit has also reached its lowest point in five quarters, with an operating profit margin of just 0.13%. Additionally, the earnings per share (EPS) have declined to Rs 1.42, indicating reduced earnings for shareholders.

These financial results have led to evaluation changes for Vasundhara Rasayans, reflecting the company's current challenges and performance metrics.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.